Additionally, alteration of the gut microbiome leads to changes in the bile-acid pool, which affects the farnesoid X receptor (FXR) nuclear antagonist involved in the regulation of bile acid, as well as lipid and glucose metabolism (Li et al., 2013), and could cause metabolic dysfunction, including obesity and insulin resistance. This evidence concerns the gene NR1H4 and obesity disorder.